QUEST DIAGNOSTICS INC (DGX) Options Risk Score
Real-time risk analysis for DGX options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full DGX options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan DGX Now — Free →
Is it risky to sell options on QUEST DIAGNOSTICS INC (DGX) right now?
QUEST DIAGNOSTICS INC (DGX) currently scores 67 out of 100 for options catalyst risk (MEDIUM) over a 4-week expiry window. That score is driven by 12 recent news items, 2 active legal filings, 1 recent SEC event and 13 clinical-trial catalysts falling inside the 4-week window. On TickerRisk's scale 45 to 69 is MEDIUM, meaning something in the 4-week window is worth checking before committing to an expiry. The score measures scheduled event exposure, not the direction DGX will move.
DGX shows an IV Rank of 87 — implied volatility is near the top of its own one-year range, so DGX options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 39%. IV Rank answers how DGX options are priced against their own history, which is the starting point for choosing between selling and buying premium.
DGX does not report again until 2026-07-23, so near-dated expiries avoid it.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer